163 related articles for article (PubMed ID: 8580272)
1. A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group.
Avner DL; Dorsch ER; Jennings DE; Greski-Rose PA
Aliment Pharmacol Ther; 1995 Oct; 9(5):521-8. PubMed ID: 8580272
[TBL] [Abstract][Full Text] [Related]
2. Lansoprazole versus omeprazole for duodenal ulcer healing and prevention of relapse: a randomized, multicenter, double-masked trial.
Dobrilla G; Piazzi L; Fiocca R
Clin Ther; 1999 Aug; 21(8):1321-32. PubMed ID: 10485504
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
[TBL] [Abstract][Full Text] [Related]
4. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
5. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
Londong W; Barth H; Dammann HG; Hengels KJ; Kleinert R; Müller P; Rohde H; Simon B
Aliment Pharmacol Ther; 1991 Jun; 5(3):245-54. PubMed ID: 1888824
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
[TBL] [Abstract][Full Text] [Related]
7. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
Hawkey CJ; Long RG; Bardhan KD; Wormsley KG; Cochran KM; Christian J; Moules IK
Gut; 1993 Oct; 34(10):1458-62. PubMed ID: 8244121
[TBL] [Abstract][Full Text] [Related]
8. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
9. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
10. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
Mee AS; Rowley JL
Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
[TBL] [Abstract][Full Text] [Related]
12. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists.
Kovacs TO; Campbell D; Richter J; Haber M; Jennings DE; Rose P
Aliment Pharmacol Ther; 1999 Jul; 13(7):959-67. PubMed ID: 10383532
[TBL] [Abstract][Full Text] [Related]
14. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
Beker JA; Bianchi Porro G; Bigard MA; Delle Fave G; Devis G; Gouerou H; Maier C
Eur J Gastroenterol Hepatol; 1995 May; 7(5):407-10. PubMed ID: 7614102
[TBL] [Abstract][Full Text] [Related]
16. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
[TBL] [Abstract][Full Text] [Related]
17. Comparison of lansoprazole and omeprazole in the short-term management of duodenal ulcers in Taiwan.
Chang FY; Chiang CY; Tam TN; Ng WW; Lee SD
J Gastroenterol Hepatol; 1995; 10(5):595-601. PubMed ID: 8963037
[TBL] [Abstract][Full Text] [Related]
18. Prevention of duodenal ulcer recurrence with 15 mg lansoprazole: a double-blind placebo-controlled study. The Lansoprazole Study Group.
Lanza F; Goff J; Silvers D; Winters J; Jhala N; Jennings D; Greski-Rose P
Dig Dis Sci; 1997 Dec; 42(12):2529-36. PubMed ID: 9440632
[TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.
Kovacs TO; Campbell D; Haber M; Rose P; Jennings DE; Richter J
Dig Dis Sci; 1998 Apr; 43(4):779-85. PubMed ID: 9558034
[TBL] [Abstract][Full Text] [Related]
20. [A clinical trial of lansoprazole in the treatment of duodenal ulcer].
Pei Y; Wang B; Chen S
Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):606-8. PubMed ID: 8697927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
